Single-cell immune profiling with TCR clonotype barcoding identifies biomarker signatures that predict response to immune checkpoint blockade
Lee, D.; Fulton, R.; Manne, M.; Schweizer, L.; Raue, A.
Show abstract
The identification of predictive biomarkers for patient treatment response is urgently needed to increase the probability of success of existing and novel experimental therapies. Single-cell profiling has provided novel biological insights into drug responses in the tumor microenvironment, but its potential for biomarker discovery has not been fully explored for therapeutic purposes. We describe a novel approach to discover predictive response biomarkers from single-cell data from a small patient cohort using the T cell receptor sequence intrinsic to each T cell to match clonotypes between pre- and post-treatment tumor samples. As a result, we have identified a predictive gene expression signature for immune checkpoint blockade and validated its predictive performance using data from three larger clinical studies. Our results demonstrated that applying clonotyping with single-cell genomic profiling is a promising novel approach for biomarker identification that does not require data collected from large patient cohorts. This could increase success rates, reduce clinical trial size, and significantly impact future clinical developments of immunomodulatory therapeutics.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: the phase I/II first-in-human MATINS trial 96%
- Conserved angio-immune subtypes of the cancer microenvironment predict response to immune checkpoint blockade therapy 94%
- Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes 94%
Similar papers in this journal
- Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study 96%
- Predicting immunotherapy response in advanced bladder cancer: a meta-analysis of six independent cohorts 96%
- Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics 95%
Similar papers in this journal
- Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+ T cells in the tumor microenvironment and predicts clinical outcome in early- and late-phase clinical trials 96%
- Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma 94%
- A Spatial Comparison of Molecular Features Associated with Resistance to Pembrolizumab in BCG Unresponsive Bladder Cancer 94%
Similar papers in this journal
- A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma 96%
- Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockade 95%
- T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H 94%
Similar papers in this journal
- Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses 95%
- Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products 95%
- CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.